Page last updated: 2024-11-07

spironolactone and Kidney, Polycystic

spironolactone has been researched along with Kidney, Polycystic in 2 studies

Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jeewandara, TM1
Ameer, OZ1
Boyd, R1
Wyse, BF1
Underwood, CF1
Phillips, JK1
Isdale, JM1
Thomson, PD1
Katz, S1

Other Studies

2 other studies available for spironolactone and Kidney, Polycystic

ArticleYear
Protective cardiorenal effects of spironolactone in a rodent model of polycystic kidney disease.
    Clinical and experimental pharmacology & physiology, 2015, Volume: 42, Issue:4

    Topics: Animals; Aorta; Biomarkers; Blood Pressure; Cytoprotection; Disease Models, Animal; Disease Progress

2015
Infantile polycystic disease of the kidneys.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1973, Oct-13, Volume: 47, Issue:40

    Topics: Child, Preschool; Chlorothiazide; Female; Guanethidine; Humans; Hydralazine; Hypertension, Renal; In

1973